Treatment of human metastatic melanoma with mouse monoclonal antibodies against GD3 ganglioside

Prog Clin Biol Res. 1989:288:383-90.

Authors

A N Houghton¹, D F Bajorin, M Lonberg, P Chapman

Affiliation

¹ Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York 10021.

PMID: 2654956

No abstract available

Publication types

Clinical Trial

MeSH terms

Animals
Antibodies, Monoclonal / therapeutic use*
Antibodies, Neoplasm / therapeutic use*
Clinical Trials as Topic
Cytotoxicity, Immunologic
Gangliosides / immunology*
Humans
Immunization
Immunoglobulin G / immunology
Immunoglobulin Idiotypes / immunology
Melanoma / secondary*
Melanoma / therapy
Mice
T-Lymphocytes / immunology

Substances

Antibodies, Monoclonal
Antibodies, Neoplasm
Gangliosides
Immunoglobulin G
Immunoglobulin Idiotypes
ganglioside, GD3